Literature DB >> 34775911

The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota.

Alba Miranda-Ribera1,2, Gloria Serena1,2, Jundi Liu3, Alessio Fasano1,2, Marcy A Kingsbury2,4, Maria R Fiorentino1,2.   

Abstract

The gut-brain axis hypothesis suggests that interactions in the intestinal milieu are critically involved in regulating brain function. Several studies point to a gut-microbiota-brain connection linking an impaired intestinal barrier and altered gut microbiota composition to neurological disorders involving neuroinflammation. Increased gut permeability allows luminal antigens to cross the gut epithelium, and via the blood stream and an impaired blood-brain barrier (BBB) enters the brain impacting its function. Pre-haptoglobin 2 (pHP2), the precursor protein to mature HP2, is the first characterized member of the zonulin family of structurally related proteins. pHP 2 has been identified in humans as the thus far only endogenous regulator of epithelial and endothelial tight junctions (TJs). We have leveraged the Zonulin-transgenic mouse (Ztm) that expresses a murine pHP2 (zonulin) to determine the role of increased gut permeability and its synergy with a dysbiotic intestinal microbiota on brain function and behavior. Here we show that Ztm mice display sex-dependent behavioral abnormalities accompanied by altered gene expression of BBB TJs and increased expression of brain inflammatory genes. Antibiotic depletion of the gut microbiota in Ztm mice downregulated brain inflammatory markers ameliorating some anxiety-like behavior. Overall, we show that zonulin-dependent alterations in gut permeability and dysbiosis of the gut microbiota are associated with an altered BBB integrity, neuroinflammation, and behavioral changes that are partially ameliorated by microbiota depletion. Our results suggest the Ztm model as a tool for the study of the cross-talk between the microbiome/gut and the brain in the context of neurobehavioral/neuroinflammatory disorders.

Entities:  

Keywords:  Gut permeability; behavior; blood-brain barrier; dysbiosis; microbiota; neuroinflammation; zonulin transgenic mouse

Mesh:

Substances:

Year:  2021        PMID: 34775911      PMCID: PMC9359372          DOI: 10.1080/21688370.2021.2000299

Source DB:  PubMed          Journal:  Tissue Barriers        ISSN: 2168-8362


  182 in total

Review 1.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

2.  Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia.

Authors:  M K Nøhr; K L Egerod; S H Christiansen; A Gille; S Offermanns; T W Schwartz; M Møller
Journal:  Neuroscience       Date:  2015-01-28       Impact factor: 3.590

3.  Maternal antibrain antibodies in autism.

Authors:  Andrew W Zimmerman; Susan L Connors; Karla J Matteson; Li-Ching Lee; Harvey S Singer; Julian A Castaneda; David A Pearce
Journal:  Brain Behav Immun       Date:  2006-10-06       Impact factor: 7.217

4.  Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis.

Authors:  P Horner; B Thomas; C B Gilroy; M Egger; D Taylor-Robinson
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

Review 5.  Gastrointestinal dysfunction in amyotrophic lateral sclerosis.

Authors:  M Toepfer; C Folwaczny; A Klauser; R L Riepl; W Müller-Felber; D Pongratz
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  1999-12

6.  Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study.

Authors:  Isabel Leiva-Gea; Lidia Sánchez-Alcoholado; Beatriz Martín-Tejedor; Daniel Castellano-Castillo; Isabel Moreno-Indias; Antonio Urda-Cardona; Francisco J Tinahones; José Carlos Fernández-García; María Isabel Queipo-Ortuño
Journal:  Diabetes Care       Date:  2018-09-17       Impact factor: 19.112

7.  Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns.

Authors:  Amnon Amir; Daniel McDonald; Jose A Navas-Molina; Evguenia Kopylova; James T Morton; Zhenjiang Zech Xu; Eric P Kightley; Luke R Thompson; Embriette R Hyde; Antonio Gonzalez; Rob Knight
Journal:  mSystems       Date:  2017-03-07       Impact factor: 6.496

8.  Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder.

Authors:  Ruth Ann Luna; Numan Oezguen; Miriam Balderas; Alamelu Venkatachalam; Jessica K Runge; James Versalovic; Jeremy Veenstra-VanderWeele; George M Anderson; Tor Savidge; Kent C Williams
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-12-11

9.  Gut microbiome alterations in Alzheimer's disease.

Authors:  Nicholas M Vogt; Robert L Kerby; Kimberly A Dill-McFarland; Sandra J Harding; Andrew P Merluzzi; Sterling C Johnson; Cynthia M Carlsson; Sanjay Asthana; Henrik Zetterberg; Kaj Blennow; Barbara B Bendlin; Federico E Rey
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

10.  Human zonulin, a potential modulator of intestinal tight junctions.

Authors:  W Wang; S Uzzau; S E Goldblum; A Fasano
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  1 in total

1.  Zonulin and blood-brain barrier permeability are dissociated in humans.

Authors:  Charlotte M Stuart; Aravinthan Varatharaj; Martin E Winberg; Pascale Galea; Henrik B W Larsson; Stig P Cramer; Alessio Fasano; Zaynah Maherally; Geoffrey J Pilkington; Åsa V Keita; Ian Galea
Journal:  Clin Transl Med       Date:  2022-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.